⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18633351 | 0.74 | — | — | |
| SCHEMBL28064604 | 0.72 | CCR1 (0.48) | — | |
| SCHEMBL28381757 | 0.72 | UHRF1 (1.00) | — | |
| SCHEMBL44068 | 0.72 | — | — | |
| SCHEMBL6363027 | 0.72 | — | — | |
| SCHEMBL29365333 | 0.72 | — | — | |
| SCHEMBL30308690 | 0.72 | DYRK1A (0.65) | — | |
| SCHEMBL1896511 | 0.72 | DYRK1A (0.65) | — | |
| SCHEMBL17377386 | 0.70 | — | — | |
| Bromide SCHEMBL5327604 | 0.70 | UHRF1 (0.94) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117693214-A | Quantum dot light-emitting device, preparation method thereof and display device | 广东聚华印刷显示技术有限公司 | 2024-03-12 | — | — | CN | claimed |
| US-20250101003-A1 | SPIROCYCLIC CAV2.3 ANTAGONISTS | LARIO THERAPEUTICS LIMITED (GB) | 2025-03-27 | — | — | US | disclosed |
| EP-4436661-A1 | SPIROCYCLIC CAV2.3 ANTAGONISTS | Lario Therapeutics Limited (GB) | 2024-10-02 | — | — | EP | disclosed |
| CN-117693214-A | Quantum dot light-emitting device, preparation method thereof and display device | 广东聚华印刷显示技术有限公司 | 2024-03-12 | — | — | CN | disclosed |
| WO-2023205595-A2 | EGFR INHIBITORS IN CANCER TREATMENT | CELYN THERAPEUTICS, INC (US) | 2023-10-26 | — | — | WO | disclosed |
| EP-3743430-B1 | AMINOPYRROLOTRIAZINES AS KINASE INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2023-08-02 | — | — | EP | disclosed |
| WO-2023125737-A1 | HETEROCYCLIC COMPOUNDS AND USE THEREOF | SILEXON AI TECHNOLOGY CO., LTD. (CN) | 2023-07-06 | — | — | WO | disclosed |
| US-20230165846-A1 | HETEROCYCLIC GLP-1 AGONISTS | GASHERBRUM BIO, INC. | 2023-06-01 | — | — | US | disclosed |
| WO-2023094827-A1 | SPIROCYCLIC CAV2.3 ANTAGONISTS | LARIO THERAPEUTICS LIMITED (GB) | 2023-06-01 | — | — | WO | disclosed |
| EP-3185865-B1 | TETRAHYDRONAPTHTYRIDINE DERIVATIVES AS MGLUR2 NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE. | MERCK SHARP & DOHME (US) | 2020-07-15 | — | — | EP | disclosed |
| US-7728025-B2 | 2-heteroaryl-substituted benzimidazole derivative | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2010-06-01 | — | — | US | disclosed |
| US-20080070928-A1 | Novel 2-Heteroaryl-Substituted Benzimidazole Derivative | MSD K.K. (JP) | 2008-03-20 | — | — | US | disclosed |
| EP-1702919-A1 | NOVEL 2-HETEROARYL-SUBSTITUTED BENZIMIDAZOLE DERIVATIVE | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2006-09-20 | — | — | EP | disclosed |
| CN-1249003-C | Bisphenol compound composition having excellent thermal stability | MITSUBISHI CHEM CORP (JP) | 2006-04-05 | — | — | CN | disclosed |
| CN-1494522-A | Bisphenol compound composition having excellent thermal stability | 三菱化学株式会社 | 2004-05-05 | — | — | CN | disclosed |
| US-6476021-B1 | Compounds having cGMP-PDE inhibitory effect | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2002-11-05 | — | — | US | disclosed |
| EP-1048666-A1 | NOVEL COMPOUNDS HAVING cGMP-PDE INHIBITORY EFFECT | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2000-11-02 | — | — | EP | disclosed |
| US-4482663-A | Rubber compositions comprising a siliceous filler in combination with an organosulfur substituted pyridine promotor | PHILLIPS PETROLEUM COMPANY (US) | 1984-11-13 | — | — | US | disclosed |
| US-3966741-A | Process for the preparation of substituted or unsubstituted 4-pyridylthioacetic acid | OCE-ANDENO B.V. (NL) | 1976-06-29 | — | — | US | disclosed |
| US-3956345-A | POLYESTER | CIBA-GEIGY AG (CH) | 1976-05-11 | — | — | US | disclosed |